Next Article in Journal
From Microenvironment Remediation to Novel Anti-Cancer Strategy: The Emergence of Zero Valent Iron Nanoparticles
Next Article in Special Issue
BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia
Previous Article in Journal
SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?
Previous Article in Special Issue
The TKI Era in Chronic Leukemias
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(1), 100; https://doi.org/10.3390/pharmaceutics14010100
Action Date Notes Link
article xml file uploaded 1 January 2022 11:24 CET Original file -
article xml uploaded. 1 January 2022 11:24 CET Update https://www.mdpi.com/1999-4923/14/1/100/xml
article pdf uploaded. 1 January 2022 11:24 CET Version of Record https://www.mdpi.com/1999-4923/14/1/100/pdf
article html file updated 1 January 2022 11:26 CET Original file -
article html file updated 31 July 2022 01:41 CEST Update https://www.mdpi.com/1999-4923/14/1/100/html
Back to TopTop